000 | 01603 a2200493 4500 | ||
---|---|---|---|
005 | 20250513091509.0 | ||
264 | 0 | _c19960731 | |
008 | 199607s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBreems, D A | |
245 | 0 | 0 |
_aIndividual stem cell quality in leukapheresis products is related to the number of mobilized stem cells. _h[electronic resource] |
260 |
_bBlood _cJun 1996 |
||
300 |
_a5370-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aBone Marrow _xdrug effects |
650 | 0 | 4 |
_aBone Marrow Diseases _xchemically induced |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aCoculture Techniques |
650 | 0 | 4 | _aColony-Forming Units Assay |
650 | 0 | 4 | _aEvaluation Studies as Topic |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFilgrastim |
650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xpharmacology |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 |
_aHematopoietic Stem Cells _xclassification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunophenotyping |
650 | 0 | 4 | _aLeukapheresis |
650 | 0 | 4 | _aLeukocyte Count |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms _xblood |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
700 | 1 | _avan Hennik, P B | |
700 | 1 | _aKusadasi, N | |
700 | 1 | _aBoudewijn, A | |
700 | 1 | _aCornelissen, J J | |
700 | 1 | _aSonneveld, P | |
700 | 1 | _aPloemacher, R E | |
773 | 0 |
_tBlood _gvol. 87 _gno. 12 _gp. 5370-8 |
|
999 |
_c8651888 _d8651888 |